Skip to content

In-Med Prognostics L3c

Country not established

Devices
1

What In-Med Prognostics L3c makes

In-Med Prognostics manufactures the NEUROShield, a medical device designed for neuroprotection and monitoring in high-risk neurological conditions.

The NEUROShield is classified as a Class II device under FDA regulations and is listed in the 510(k) clearance registry. The company is based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • NEUROShield Ref K220034

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does In-Med Prognostics L3c have in the registry?

The registry currently lists 1 device for In-Med Prognostics L3c. Devices recorded under merged duplicate company entries are counted once.

Which registries list In-Med Prognostics L3c's devices?

Among its 1 most recently registered device, In-Med Prognostics L3c has devices listed in FDA 510(k) (1 device).

What risk classes do In-Med Prognostics L3c's devices fall under?

Among its 1 most recently registered device, the classes recorded for In-Med Prognostics L3c's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from In-Med Prognostics L3c in the registry?

The most recently registered devices listed for In-Med Prognostics L3c include NEUROShield.

Generated automatically from registry data and not verified by a human reviewer.